NgoZMayedaSYuS, et al.A novel decision tree for performing risk assessments of biologics in a health-system setting. J Oncol Pharm Practice2025; 31: 827–834.
2.
NIOSH List of Hazardous Drugs in Healthcare Settings,2024. Published online December 19, 2024. doi:10.26616/ NIOSHPUB2025103.
3.
FungESParkerJAPowellAM, et al.Estimating inhalation bioavailability for peptides and proteins 1 to 10 kDa in size. Regul Toxicol Pharmacol2023; 137: 105314.
4.
AdjeiAGarrenJ. Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers. Pharm Res1990 Jun; 7: 565–569. PMID: 2114618.
5.
PfisterTDolanDBercuJ, et al.Bioavailability of therapeutic proteins by inhalation–worker safety aspects. Ann Occup Hyg2014; 58: 899–911.
6.
GouldJCCarvajalIDavidsonT, et al.Bioavailability of protein therapeutics in rats following inhalation exposure: relevance to occupational exposure limit calculations. Regul Toxicol Pharmacol2018; 100: 35–44.
